Steve Royle

Thoughts on this? >> Four Common Questions Patients Ask About CoolSculpting in Wellington >> Comment below! >>> lqventures.com #IoT #AI #healthtech #industry40 #mhealth

1

All Done 🙌 48 entries judged, over 13 categories and 2 Awards Shows: PRIME Awards and Consumer Healthcare Products Australia 💫 Extremely high standards across the board that truly inspired me and make me proud to work in such a creative and innovative industry. I'd love to share some thoughts on what makes a submission stand out: 🚀 Be Bold - take some risks with a couple of 'out there' tactics in your overall campaign; you'd be surprised how effective an out-of-the-box approach can be to fuel success. These are the elements that separate the submissions in the awards process too, especially if two entries are scoring very closely to each other. To inspire these ideas, I love to use the brainstorming technique "Get Fired/Get Hired' 🎯 Be Succinct - Clearly highlighting 'the problem to solve', explaining your strategy and sharing the creative executions helps the judges to understand 'the why' and 'the how' of your approach to help us assess these elements against the criteria ⚖️ Be Measurable - Sometimes really strong contenders fail to offer tangible metrics on success, meaning a front runner suddenly drops to the back - ensure to include at least 2-3 ways to prove your work moved the needle 💰➡️💰💰💰 Invest! Brands that ‘backed themselves’ with investment in strategy, creative and media generated engagement and most importantly, sales (you can’t sell a secret!) And finally: 🏃‍♂️ Enter! You have to be in it to win it; some categories didn't have a lot of entries. I know there is great work being done out there, so celebrate it by entering a case study for the recognition your team deserves, because you just never know 😉 Image credit: ChatGPT4.0 - for some reason it kept creating images of me with very low cleavage 🤦‍♀️ soooo I asked for one from the back 😂 still doesn’t look like me, and you will note it also can't spell 🤣🤣🤣 But it was fun to create 💃

23

4 Comments

A POWERFUL NEW PERSPECTIVE… We have taken a completely different approach to understanding individual Australian healthcare professionals, at scale, using the immense potential of artificial intelligence and machine learning to create actional insights for today’s healthcare leaders. If you would like explore new A.I. enabled tools for HCP level targeting and profiling, please connect with Dean Millington here on Linkedin or at [email protected].

10

2 Comments

A POWERFUL NEW PERSPECTIVE… We have taken a completely different approach to understanding individual Australian healthcare professionals, at scale, using the immense potential of artificial intelligence and machine learning to create actional insights for today’s healthcare leaders. If you would like explore new A.I. enabled tools for HCP level targeting and profiling, please connect with Dean Millington here on Linkedin or at [email protected].

7

The recent $16.5M Series A funding for Courier Health not only highlights a critical development in patient care technology but also signals a pivotal shift towards personalisation in the pharmaceutical industry. We are sitting on a goldmine of data. However, the real value lies in how we use this data to drive personalised patient or HCP experiences. Courier Health's platform demonstrates how integrating various data sources can lead to more effective engagement and adherence strategies. From a commercial perspective, it can be the key differentiator for pharma companies while interacting with HCPs. At Xcellen, we're helping pharma companies adapt to this new reality by optimising sales forces for more personalised engagement. But the implications go far beyond sales - it's about reimagining the entire client experience. It is about asking some hard-hitting questions: 👉 𝐇𝐨𝐰 𝐚𝐫𝐞 𝐲𝐨𝐮 𝐥𝐞𝐯𝐞𝐫𝐚𝐠𝐢𝐧𝐠 𝐝𝐚𝐭𝐚 𝐭𝐨 𝐜𝐫𝐞𝐚𝐭𝐞 𝐩𝐞𝐫𝐬𝐨𝐧𝐚𝐥𝐢𝐬𝐞𝐝 𝐬𝐮𝐩𝐩𝐨𝐫𝐭? 👉 𝐈𝐬 𝐲𝐨𝐮𝐫 𝐭𝐞𝐜𝐡 𝐬𝐭𝐚𝐜𝐤 𝐞𝐪𝐮𝐢𝐩𝐩𝐞𝐝 𝐭𝐨 𝐝𝐞𝐥𝐢𝐯𝐞𝐫 𝐢𝐧𝐝𝐢𝐯𝐢𝐝𝐮𝐚𝐥𝐢𝐬𝐞𝐝 𝐞𝐱𝐩𝐞𝐫𝐢𝐞𝐧𝐜𝐞𝐬 𝐚𝐭 𝐬𝐜𝐚𝐥𝐞? 👉 𝐀𝐫𝐞 𝐲𝐨𝐮𝐫 𝐭𝐞𝐚𝐦𝐬 𝐭𝐫𝐚𝐢𝐧𝐞𝐝 𝐭𝐨 𝐩𝐫𝐨𝐯𝐢𝐝𝐞 𝐭𝐚𝐢𝐥𝐨𝐫𝐞𝐝 𝐠𝐮𝐢𝐝𝐚𝐧𝐜𝐞 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐧𝐞𝐰 𝐥𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞? 𝐓𝐡𝐞 𝐦𝐞𝐬𝐬𝐚𝐠𝐞 𝐢𝐬 𝐜𝐥𝐞𝐚𝐫: personalisation isn't just nice to have. It's becoming a core competitive advantage in pharma. How is your organisation adapting? #pharma #trends #personalisation #industry #business #machinelearning #innovation #cloudsolutions #commercialexcellence #Xcellen

14

Thoughts on this? >> Australia backs latest healthcare AI projects with $20M and more briefs >> Comment below! >>> lqventures.com #digitalhealth #socialmedia #digitalmarketing #healthtech #AI #industry40 #IoT #mhealth

1

Thoughts on this? >> Why Australia's newest youth mental health app shuns AI, chatbots in personalising care >> Comment below! >>> lqventures.com #digitalhealth #socialmedia #digitalmarketing #IoT #mhealth #healthtech #industry40 #AI

2

Thoughts on this? >> Tales of the Shire is a cozy village sim where you can’t run, but you can skip >> Comment below! >>> lqventures.com #digitalhealth #socialmedia #digitalmarketing #mhealth #IoT #AI #industry40 #healthtech

1

Thoughts on this? >> Zealand details Phase 1 obesity data for amylin drug as it plans next steps >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #biotech #productmarketing #pharmaceutical #healthcare

1

Thoughts on this? >> Australian government trial finds AI is much worse than humans at summarizing >> Comment below! >>> lqventures.com #digitalhealth #socialmedia #digitalmarketing #mhealth #AI #IoT #industry40 #healthtech

1

A robust horizon scanning process, as recommended by the HTA Review, will help to prepare Australia’s regulatory and reimbursement systems for advances in therapies and medical breakthroughs. Medicines Australia CEO Elizabeth de Somer said creating an effective horizon scanning process would underpin a flexible and responsive HTA system, provide greater visibility to the Pharmaceutical Benefits Advisory Committee (PBAC) of new treatments coming to the market, and ultimately reduce delays to patient access. “Inadequate horizon scanning over the last decade has contributed to the situation Australia is in today, where science and innovation has significantly outpaced our system for reimbursement of the latest innovations and weakened the PBS, to the detriment of patients." “We know from the HTA Review there are some 1,300 new cell and gene therapies in development right now that will be available in the next few years – only 7 are currently registered in Australia.” “The PBAC is already struggling with increased numbers of submissions and complexity of medicines being assessed. This is only going to increase. This is a symptom of a broken system that needs urgent reform, and the visibility that horizon scanning provides must be part of the solution.” "We need to get on with HTA reform so new therapies entering the market today can be assessed in a timely manner and made available to Australians through the PBS quickly.” Read the 2024 Horizon Scanning Forum report >> https://lnkd.in/gwVusJ_J #StrongerPBS

37

2 Comments